首页 › 基金 › PERCEPTIVE ADVISORS LLC › STRO

PERCEPTIVE ADVISORS LLC 对 STRO 的持仓历史

SUTRO BIOPHARMA INC · 医疗保健

PERCEPTIVE ADVISORS LLC 在 Q2 2026 的 13F 申报中披露持有 STRO(SUTRO BIOPHARMA INC)1,304,846 股,市值约 US$43.3M,约占其申报组合的 0.69%,在其申报持仓中市值排名第 32 位。 PERCEPTIVE ADVISORS LLC 最近 2 个申报季度中有 2 个季度披露了 STRO 持仓,最早可追溯至 Q1 2026。

最新持仓 (Q2 2026)1.30M 股
申报持仓市值$43.32M
组合权重0.69%
首次申报Q1 2026
最近变动增持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

PERCEPTIVE ADVISORS LLC 对 STRO 的持仓演变

PERCEPTIVE ADVISORS LLC 于 Q1 2026 首次披露 STRO 持仓:715,307 股(约 US$17.8M)。 该持仓在 Q2 2026 达到峰值 1,304,846 股,市值约 US$43.3M。 在 2 次申报中,PERCEPTIVE ADVISORS LLC 1 次增持、0 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 1,304,846 股、市值约 US$43.3M,环比增持 589,539 股。。 持仓曾出现大幅变动:Q2 2026 增持约 82% (随后一个季度股价下跌 51%)。

逐季持仓明细

季度股数金额变化
Q1 2026 715.31K $17.82M 新进
Q2 2026 1.30M $43.32M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 STRO 与 13F 数据

STRO(SUTRO BIOPHARMA INC)属于医疗保健行业。我们追踪的基金中还有 45 只申报持有 STRO,申报仓位最大的包括:BVF INC/IL (US$41.6M), Affinity Asset Advisors, LLC (US$38.9M), Samsara BioCapital, LLC (US$35.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 STRO 的基金

查看 STRO 的全部基金持有人 →

常见问题

How long has PERCEPTIVE ADVISORS LLC held STRO?

PERCEPTIVE ADVISORS LLC has disclosed STRO holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is PERCEPTIVE ADVISORS LLC's current position in STRO?

As of Q2 2026, PERCEPTIVE ADVISORS LLC holds 1.30M shares of STRO (SUTRO BIOPHARMA INC), valued at $43.32M, representing 0.69% of its reported portfolio and ranking #32.

Has PERCEPTIVE ADVISORS LLC been buying or selling STRO?

In the latest 13F filing (Q2 2026), PERCEPTIVE ADVISORS LLC increased its position in STRO. The position peaked in Q2 2026 at 1.30M shares.

Which other funds hold STRO?

Other major institutional holders of STRO include BVF INC/IL, Affinity Asset Advisors, LLC, Samsara BioCapital, LLC, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.